Treatment method objectives. Each GLP-1 agonist has distinct approved uses and possible Gains that may help you meet up with your remedy plans. In Oct 2024, Novo Nordisk posted a analyze on scientific journal Mother nature about a novel glucose-delicate insulin NNC2215 which will cut down the